Deborah Sterling

[Deborah Sterling @BiotechIPlawyer]

Sterne Kessler is pleased to announce our litigation team successfully represented Teva Pharmaceuticals in securing a non-infringement victory. On December 29, 2023, the district court held that Teva does not infringe the two patents asserted at trial… https://t.co/7kHlyrUe4u

[Deborah Sterling @BiotechIPlawyer]

Sterne Kessler is thrilled to announce that six attorneys have been elected to our directorship. Managing Director Michael B. Ray remarked how “their individual expertise, unwavering commitment to excellence, and dedication to positive client outcomes… https://t.co/HOvfjmgWnu

[Deborah Sterling @BiotechIPlawyer]

Sterne Kessler secured a patent infringement victory for our client SweeGen Inc. at the U.S. Court of Appeals for the Federal Circuit for their natural non-caloric sweetener that is used in food and drinks. The Federal Circuit affirmed a district court… https://t.co/8TFLQEfXvm

[Deborah Sterling @BiotechIPlawyer]

Read the December issue of the firm's MarkIt to Market newsletter and be sure to subscribe to receive the latest trademark updates. https://t.co/f2LiR4JIQC

[Deborah Sterling @BiotechIPlawyer]

We’re excited to welcome our new CFO, Pat Hennessy, to the team! Pat brings 30+ years of progressive financial experience & we look forward to soaring to even greater heights with his guidance. https://t.co/yJr8l6lRkg

[Deborah Sterling @BiotechIPlawyer]

Now Open - 1L Summer Associate Diversity & Inclusion Fellowship program! Our paid 1L Fellows are paired with Sterne Kessler attorneys for mentoring in addition to working and training with our 2L Summer Associates through an in-depth training program. https://t.co/CI7K8a80xV

[Deborah Sterling @BiotechIPlawyer]

Sterne Kessler's Mechanical & Design Practice Group got together for their annual holiday lunch and gift swap! Our culture plays an integral role in our success, and the success of our clients. Visit our website to learn more about our firm and culture! https://t.co/NctZaMtxlN

[Deborah Sterling @BiotechIPlawyer]

Directors John Covert and Gaby Longsworth, Ph.D. presented the webinar “Patent Term Extension Considerations for BioPharma Patents.” Read our webinar Q&A highlights and watch the On-Demand recording to learn more! #PTE #biopharma https://t.co/47SmP7qMYz

[Deborah Sterling @BiotechIPlawyer]

At Sterne Kessler, we’re always excited to help inventors turn their ideas into reality as they create products that impact our daily lives. The Wheelchair Walker prevents the user from falling while walking. https://t.co/XGJ53PRiiw https://t.co/fJbjQwydhR

[Deborah Sterling @BiotechIPlawyer]

Our Bio & Chemical Practice Group recently hosted its last quarterly BioWeek of 2023 in DC. The group also used the time to give back for the holidays to support of the House of Ruth by fulfilling the gift wishes for nine families.https://t.co/DBkUiCevt8 https://t.co/pPbHR3YsdP

[Deborah Sterling @BiotechIPlawyer]

Sterne Kessler is excited to announce the launch of our second IP law writing competition. Law students have the chance to win $10K (1st place), $5K (2nd place), or $2,500 (3rd place).
Deadline to submit is 5:00 p.m. EST on January 31, 2024. Read more! https://t.co/pV8l4hWyKu

[Deborah Sterling @BiotechIPlawyer]

Sterne Kessler gives back! To celebrate the season of giving, our Trademark Practice once again partnered with Stockings from Karen (SFK) to fill stockings for the holidays in our DC office. Visit https://t.co/sdGFP3FNaE for more information. https://t.co/yypmeSEX4j

[Deborah Sterling @BiotechIPlawyer]

Some exciting news was recently announced regarding the latest pilot program initiated by the USPTO in the realm of semiconductor technology. Read our latest IP Hot Topic, "USPTO's Latest Pilot Program in Semiconductor Technology." #USPTO #Semiconductors https://t.co/mVRm0jMHzr

[Deborah Sterling @BiotechIPlawyer]

Thank you to Consero for hosting the 2023 IP Life Sciences Forum earlier this month! Sterne Kessler was pleased to be a sponsor of this well-attended event and to network with industry colleagues and peers. #Consero #ConseroIPL #IntellectualProperty https://t.co/GwcB2l3oOz

[Deborah Sterling @BiotechIPlawyer]

Director Jason Fitzsimmons and Counsel Richard Crudo recently presented the webinar “Developments in IPR Estoppel,” Read our key takeaways for some best practices for companies and practitioners! #PTAB #IPRestoppel #IP https://t.co/h2gR6YQhgB

[Deborah Sterling @BiotechIPlawyer]

Director Peter Jackman and Law Clerk Bree Vculek discuss the latest developments and types of IP protection available for plant varieties in their article published by Lexology and AIPLA. Read it today! #plants #plantbreeding #innovation #agriculture https://t.co/liBbmkdxvy

[Deborah Sterling @BiotechIPlawyer]

The PTAB recently denied a petition seeking post-grant review of a cancer treatment patent held by Sterne Kessler client The University of Texas System, and developed by the MD Anderson Cancer Center. Read the Law360 article today! https://t.co/5Uwy1tELWM

[Deborah Sterling @BiotechIPlawyer]

We are gearing up for Geek Week II at Sterne Kessler, Dec 5-7! Geek Week was launched earlier this year, with our Electronics Group gathering in DC to collaborate and share new ideas as a team. #SKGFGeekWeek #IntellectualProperty https://t.co/vISwuwTqRz

[Deborah Sterling @BiotechIPlawyer]

Sterne Kessler successfully secured denial of a post-grant review petition at the PTAB on behalf of the patent owner Board of Regents, The University of Texas System. Read our announcement to learn more. https://t.co/ZPdkS6uHQR

[Deborah Sterling @BiotechIPlawyer]

Congratulations to Directors Tracy-Gene G. Durkin, Jorge A. Goldstein, Ph.D., Michael Q. Lee, and Robert Greene Sterne on being named to the 2024 IAM Global Leaders rankings! Read our news release to learn more.
#IntellectualProperty #PatentLaw https://t.co/t7VE6IrqEc